Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sanofi-Aventis S.A. ADR (SNY)

Sanofi-Aventis S.A. ADR (SNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 132,831,008
  • Shares Outstanding, K 2,527,226
  • Annual Sales, $ 46,348 M
  • Annual Income, $ 7,362 M
  • 60-Month Beta 0.50
  • Price/Sales 2.94
  • Price/Cash Flow 9.59
  • Price/Book 1.61
Trade SNY with:

Options Overview Details

View History
  • Implied Volatility 25.88% ( -0.47%)
  • Historical Volatility 27.36%
  • IV Percentile 72%
  • IV Rank 45.97%
  • IV High 38.14% on 03/07/22
  • IV Low 15.45% on 05/24/21
  • Put/Call Vol Ratio 0.12
  • Today's Volume 148
  • Volume Avg (30-Day) 216
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 21,076
  • Open Int (30-Day) 21,174

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.85
  • Number of Estimates 2
  • High Estimate 0.88
  • Low Estimate 0.82
  • Prior Year 0.83
  • Growth Rate Est. (year over year) +2.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.66 +4.71%
on 05/11/22
56.22 -5.65%
on 04/21/22
-2.70 (-4.85%)
since 04/14/22
3-Month
47.73 +11.14%
on 03/04/22
58.10 -8.70%
on 04/11/22
+0.18 (+0.33%)
since 02/17/22
52-Week
46.92 +13.04%
on 12/03/21
58.10 -8.70%
on 04/11/22
-0.44 (-0.83%)
since 05/17/21

Most Recent Stories

More News
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.

SNY : 52.90 (+0.65%)
RGLS : 0.2014 (+6.56%)
ONTX : 1.1900 (+8.68%)
SLNO : 0.1903 (+7.64%)
How Novo Nordisk Will Protect Insulin Sales

Advancing insulin technology promises a better patient experience.

NVO : 106.34 (+3.00%)
LLY : 301.40 (+0.67%)
SNY : 52.90 (+0.65%)
Heart Failure Treatment Offers Hope to Diabetics

Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart...

CRDL : 1.2700 (+12.39%)
CRDL.TO : 1.62 (+10.96%)
LLY : 301.40 (+0.67%)
NVO : 106.34 (+3.00%)
SNY : 52.90 (+0.65%)
Why GSK May Have Bet Too Big on a Pandemic Pipeline

Its late-stage pipeline is heavily weighted toward pandemic treatments.

GSK : 44.71 (+0.77%)
SNY : 52.90 (+0.65%)
PFE : 51.34 (+1.32%)
MRNA : 142.28 (+4.42%)
AZN : 65.64 (+1.78%)
NVAX : 51.95 (+8.23%)
3 Top Biotech Stocks to Buy Right Now

These three pharma stocks each pay market-beating dividends to shareholders.

SNY : 52.90 (+0.65%)
PFE : 51.34 (+1.32%)
AZN : 65.64 (+1.78%)
Regeneron (REGN) Q1 Earnings Beat, COVID Antibody Sales Affected

Regeneron (REGN) beats on Q1 earnings and sales record year-over-year growth on the solid performance of Dupixent and Eylea.

REGN : 667.56 (+1.92%)
SNY : 52.90 (+0.65%)
RHHBY : 40.4300 (+0.77%)
BAYRY : 16.9400 (+2.67%)
Will Eylea, Dupixent Buoy Regeneron's (REGN) Q1 Earnings?

Regeneron's (REGN) first-quarter performance might have gotten a boost from the solid performance of Eylea and Dupixent.

REGN : 667.56 (+1.92%)
SNY : 52.90 (+0.65%)
VRTX : 261.84 (+3.02%)
CLVS : 0.7814 (-5.76%)
Sanofi (SNY) Q1 2022 Earnings Call Transcript

SNY earnings call for the period ending March 31, 2022.

SNY : 52.90 (+0.65%)
Seagen's (SGEN) Q1 Earnings & Revenues Surpass Estimates

Seagen (SGEN) reports narrower-than-expected loss in the first quarter of 2022 while its revenues beat estimates.

SNY : 52.90 (+0.65%)
RHHBY : 40.4300 (+0.77%)
MRK : 93.00 (+0.74%)
SGEN : 146.55 (+2.81%)
BioMarin (BMRN) Q1 Earnings and Revenues Beat Estimates

Biomarin Pharmaceutical's (BMRN) first-quarter earnings and sales beat estimates. BMRN also raises its financial guidance for 2022 Voxzogo sales by $10 million.

SNY : 52.90 (+0.65%)
BMRN : 79.12 (+2.33%)
VRTX : 261.84 (+3.02%)
DCPH : 11.43 (+7.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sanofi-Aventis manufactures & markets prescription drugs across countries. It focuses on major therapeutic areas such as multiple sclerosis, cardiovascular, immunology, neurology, oncology, rare blood disorders & diabetes, etc. By taking Genzyme Corporation as a subsidiary, it added products like Cerezyme,...

See More

Key Turning Points

3rd Resistance Point 53.60
2nd Resistance Point 53.12
1st Resistance Point 52.84
Last Price 52.90
1st Support Level 52.08
2nd Support Level 51.60
3rd Support Level 51.32

See More

52-Week High 58.10
Fibonacci 61.8% 53.83
Last Price 52.90
Fibonacci 50% 52.51
Fibonacci 38.2% 51.19
52-Week Low 46.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar